Sunday, 23 February 2020

Generics News

  • Simcere Pharma sells Boda subsidiary for $65 mn

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2013

    Singapore: Simcere Pharma has agreed to sell its 99.99 percent stake in Jilin Boda Pharma for $65 million. The company from Nanjing had initially bought 51 percent ownership of Boda in 2007...Read more

  • Actavis files ANDA for Reckitt generic with FDA

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 10 Oct, 2013

    Singapore: Actavis has filed an abbreviated new drug application (ANDA) with the US FDA seeking approval to market Buprenorphine Hydrochloride and Naloxone Hydrochloride Sublingual Film 2 m...Read more

  • Teva restructures organization model

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2014

    Singapore: Global pharmaceutical company, Teva Pharmaceutical, is restructuring its management and organizational function to enhance company's position in the global market. Effective July...Read more

  • Bayer appoints a new President

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2014

    Singapore: Bayer pharmaceuticals announced changes in the top management, declaring Mr Dieter Weinand as the president of Bayer HealthCare Pharmaceuticals, effective from August 1, 2014. M...Read more

  • Lupin begins trial runs at Nagpur's Mihan unit

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 12 Aug, 2013

    Mumbai: Indian drug giant Lupin Pharma has begun trial run at Mihan that it expects to become fully functional in two years. The Nagpur unit will export drugs to US. After Tata Aeronautics...Read more

  • Dr. Reddy's launches generic of Singulair oral granules

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 28 Sep, 2012

    Bangalore: India-based Dr. Reddy's Laboratories has launched its montelukast sodium oral granules, a bioequivalent generic version of Singulair oral granules in the US market. The launch f...Read more

  • Daiichi Sankyo generics' unit to launch 5 drugs

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 17 Dec, 2012

    Singapore: Daiichi Sankyo's pharmaceuticals subsidiary, Daiichi Sankyo Espha is all set to launch five generic products Quetiapine tablets 25 mg DSEP, Quetiapine tablets 100 mg DSEP and Que...Read more

  • Aurobindo receives FDA approval for Nevirapine

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

    Bangalore: India-based Aurobindo Pharma has received final approval from the US Food & Drug Administration for Nevirapine tablets 200mg and Nevirapine oral suspension 50mg/5mL. The pro...Read more

  • Another Indian pharma company rapped by FDA

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 22 Oct, 2013

    Singapore: After reports of Indian drug majors Ranbaxy Laboratories, Aurobindo Pharma, Dr Reddy's Laboratories and Wockhardt coming under the strict scrutiny of the US drug regulator, anoth...Read more

  • Mitsubishi Tanabe files NDA for Canagliflozin

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 30 May, 2013

    Singapore: Mitsubishi Tanabe Pharma announced that the company has submitted an application for the manufacturing and marketing approval of TA-7284 (Canagliflozin), a sodium glucose co-tran...Read more

  • Mylan to develop, market Biocon generic insulin

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 14 Feb, 2013

    Bangalore: India's No 2 biotech company, Bangalore-based Biocon has announced a strategic partnership with global generics major, Mylan, based in Pittsburgh, US, to sell its three insulin a...Read more

  • Australia's Mayne Pharma launches Doryx in US

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2013

    Singapore: Mayne Pharma Group has announced the launch of Doxycycline Hyclate Delayed-Release tablet in the US through their generic products division. According to IMS Health, Doxycycline...Read more

  • The US coaxing India to relax patent laws: MSF

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 20 Oct, 2014

    Singapore: Medical Charity, Medecins Sans Frontieres (MSF) has condemned the US for mounting pressure on India's new government to relax the strict patent conditions, governing the country'...Read more

  • FDA approves Novo Nordisk haemophilia A drug

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 17 Oct, 2013

    Singapore: U.S. Food and Drug Administration (FDA) has approved Novo Nordisk's Biologics License Application (BLA) for recombinant coagulation factor VIII, Novoeight. Novoeight is approved...Read more

  • Sun Pharma settles Gleevec compound litigation

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 20 May, 2014

    Singapore: Novartis Pharmaceuticals has reported to settle its litigation with US subsidiary of India based Sun Pharmaceutical Industries relating to Novartis patents covering the use of ce...Read more

  • Bayer's CEO to step down by 2016

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jun, 2014

    Singapore: German drugmaker Bayer announced that Dr Marjin Dekkers will step down as the CEO, by the end of 2016. The firm said that Mr Dekkers' contract which was to expire at the end of t...Read more

  • Lupin gets FDA approval for Lyrica generic

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 06 Jul, 2012

    Mumbai: Pharma major Lupin's subsidiary, Lupin Pharmaceuticals, has received final approval for its pregabalin capsules, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg from ...Read more

  • Indian state to slash prices of 348 drugs

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2013

    Singapore: Tripura has become the first Indian state to announce its implementation of the country's health ministry's decision to reduce the maximum retail prices of essential drugs. The ...Read more